Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-07

FDA Approved: GANIRELIX ACETATE — Original Application (Amphastar Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Ganirelix acetate as an Original Application generic to prevent premature ovulation during controlled ovarian stimulation in assisted reproductive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganirelix acetate (ganirelix acetate)

Snippet

ORIG AP for GANIRELIX ACETATE (GANIRELIX ACETATE)